Showing results (661-670 of 868) with videos related to
Sort By:
Pageof 87
Environmental Science & Technology|October 31, 2015
Quantifying and Reducing Uncertainty in Estimated Microcystin Concentrations from the ELISA MethodSong S Qian, Justin D Chaffin, Mark R DuFour, et al.Neuropharmacology|September 12, 2018
The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesiaAndrew J Flores, Mitchell J Bartlett, Brandon K Root, et al.Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Exploring the Utility of a Functional Magnetic Resonance Imaging (fMRI) Cannabis Cue-Reactivity Paradigm in Treatment Seeking Adults with Cannabis Use DisorderGregory L Sahlem, Logan T Dowdle, Nathaniel L Baker, et al.Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|September 26, 2024
Exploring the Utility of a Functional Magnetic Resonance Imaging Cannabis Cue-Reactivity Paradigm in Treatment-Seeking Adults With Cannabis Use DisorderGregory L Sahlem, Logan T Dowdle, Nathaniel L Baker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Using patients as their own controls for cost evaluation of phase I clinical trialsEric J Sherman, David M Rubin, Ennapadam Venkatraman, et al.International Journal of Molecular Sciences|March 13, 2024
Evaluating Temperature Effects on Bluetongue Virus Serotype 10 and 17 Coinfection in Culicoides sonorensisMolly Carpenter, Jennifer Kopanke, Justin Lee, et al.World Neurosurgery|October 28, 2023
Early Postoperative Seizures Following Awake Craniotomy and Functional Brain Mapping for LesionectomyBrin E Freund, Anteneh M Feyissa, Aafreen Khan, et al.The Journal of Pain|October 18, 2017
Comparing Pain and Depressive Symptoms of Chronic Opioid Therapy Patients Receiving Dose Reduction and Risk Mitigation Initiatives With Usual CareManu Thakral, Rod L Walker, Kathleen Saunders, et al.Biorxiv : the Preprint Server for Biology|March 13, 2023
Type I interferon signaling induces a delayed antiproliferative response in Calu-3 cells during SARS-CoV-2 infectionJuliana Bragazzi Cunha, Kyle Leix, Emily J Sherman, et al.Proceedings of the National Academy of Sciences of the United States of America|April 24, 2024
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamicsDavid J Sherman, Lei Liu, Jennifer L Mamrosh, et al.Pageof 87